AI assistant
Sending…
ANGIODYNAMICS INC — Director's Dealing 2021
Jul 27, 2021
32939_dirs_2021-07-27_b2668e7b-50e7-4c56-a92d-4ccb6c531ea0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2021-07-21
Reporting Person: Piccinini Laura (SVP International)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 10000 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) | $26.49 | 2031-06-01 | Common Stock (50000) | Direct |
Footnotes
F1: These shares of common stock of AngioDynamics, Inc. ("Common Stock") represent 10,000 shares of Common Stock underlying restricted stock units which vest in four equal annual installments beginning on June 1, 2022, such that 25% of the restricted stock units will vest on each of June 1, 2022, 2023, 2024 and 2025.
F2: These stock options vest in four equal annual installments beginning on June 1, 2022, such that 25% of the options will vest on each of June 1, 2022, 2023, 2024 and 2025.
More from ANGIODYNAMICS INC
Regulatory Filings
2026
Apr 23
Interim / Quarterly Report
2026
Apr 2
Regulatory Filings
2026
Apr 2
Major Shareholding Notification
2026
Mar 26
Major Shareholding Notification
2026
Feb 13
Major Shareholding Notification
2026
Feb 10
Regulatory Filings
2026
Feb 3
Regulatory Filings
2026
Jan 14
Major Shareholding Notification
2026
Jan 8
Regulatory Filings
2026
Jan 6